Detalles de la búsqueda
1.
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.
Ann Oncol;
32(5): 609-619, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33610734
2.
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
Ann Oncol;
31(2): 228-235, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959339
3.
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study.
Ann Oncol;
30(9): 1487-1495, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240302
4.
EVITA-a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.
Ann Oncol;
29(4): 1010-1015, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360920
5.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Ann Oncol;
29(10): 2052-2060, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30052729
6.
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma.
Ann Oncol;
27(4): 673-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26747859
7.
Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial.
Ann Oncol;
27(12): 2203-2210, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27753609
8.
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Ann Oncol;
27(8): 1565-72, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27234640
9.
A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors.
BMC Cancer;
16: 420, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27387446
10.
[HER2 testing in gastric cancer - results of a German expert meeting]. / HER2-Testung beim Magenkarzinom - Ergebnisse eines deutschen Expertentreffens.
Z Gastroenterol;
54(8): 791-6, 2016 Aug.
Artículo
en Alemán
| MEDLINE | ID: mdl-27529529
11.
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).
Ann Oncol;
26(6): 1244-1248, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25755108
12.
[Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism]. / Östrogenrezeptoren und ihre Bedeutung für die Prognose und Therapie des Lungenkarzinoms - neue Erkenntnisse zu einem bisher unterschätzten Mechanismus.
Pneumologie;
69(6): 350-60, 2015 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-26069097
13.
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer.
Br J Cancer;
108(3): 519-26, 2013 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23322206
14.
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.
Br J Cancer;
108(2): 265-70, 2013 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23329236
15.
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy.
Ann Oncol;
24(8): 2068-73, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23592699
16.
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Ann Oncol;
24(10): 2581-2588, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975664
17.
Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.
Ann Oncol;
29(12): 2393-2395, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30307464
18.
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology.
ESMO Open;
8(5): 101623, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37742484
19.
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer.
Ann Oncol;
23(7): 1699-705, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22112973
20.
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.
Ann Oncol;
23(10): 2656-2662, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22689179